Predictive High-Content/High-Throughput Assays for Hepatotoxicity Using

There is great interest in using iPSC-derived hepatocytes as tools for screening in drug development. While unlimited supply of such cells from multiple donors addresses one common bottleneck, it is yet to be shown that iPSC-derived hepatocytes are amenable to high-throughput and high-content screening analyses. In this poster read about the testing of several automated screening approaches for assessing general and mechanism-specific hepatotoxicity.